Lawmakers consider restrictions to needle exchange programs
A bipartisan group of lawmakers representing Sanford is sponsoring the legislation, which went to a public hearing Monday. If ...
MyChesCo on MSN1d
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...
Renal & Urology News3d
FDA Approves Cortrophin Gel in Prefilled Syringe Presentation
The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.
The Nation Newspaper3d
Sanwo-Olu unveils Lagos first medical syringe manufacturing plant
Lagos State Governor, Babajide Sanwo-Olu, has inaugurated the state’s first medical syringe manufacturing facility, O-Care ...
Business Wire8d
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
The initial container systems will include 0.5 mL, 1 mL long, and 1 mL short syringes, along with 2R vials, all in ready-to-fill formats. Container filling can be performed via peristaltic pump or ...
The Punch12d
NAFDAC alerts Nigerians on circulation of substandard insulin syringes
The National Agency for Food and Drug Administration and Control has raised the alarm over the illegal circulation and ...
Vanguard14d
NAFDAC warns against circulation of substandard insulin syringes
NAFDAC further warned that this syringe is no longer registered and its continued use poses a serious risk of dosing errors, ...
TheCable14d
ALERT: NAFDAC warns Nigerians against fake Knowit insulin syringe in circulation
The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigeriams about the illegal circulation and marketing of a substandard and falsified Knowit Insulin Syringe 40 IU ...
Finanznachrichten14d
ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel Prefilled Syringe
PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified ...
Business Wire14d
Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi ® (ustekinumab-aauz)
Otulfi will be available in the U.S. in the following presentations: a 45 mg/0.5 mL and 90 mg/mL single-dose prefilled syringe for injection and a 130 mg/26 mL (5 mg/mL) single dose vial for IV ...